[Noninvasive insulin delivery systems].
The review considers commercial insulin formulations. Special attention is paid to the difficulties and strategies of development of alternative hormone delivery systems (buccal, transdermal, intranasal, pulmonary and oral). At the moment there is only one approved formulation of the noninvasive insulin in the world.
Zubaerova
D Kh
DKh
Larionova
N I
NI
D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D004333:Drug Administration Routes; D016503:Drug Delivery Systems; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage* / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D007328:Insulin